Amount Raised
$200 Million
Round Type
Series B
BeijingBiotechnologyHealth CareTherapeuticsDescription
Sironax, an emerging biotechnology company dedicated to the discovery and global development of novel treatments for patients with age-related degenerative diseases, today announced the completion of a $200 million Series B financing. The round was led by Gaorong Capital and Yunfeng Capital, with participation from existing investors including Temasek, Invus, F-Prime Capital, Eight Roads, ARCH Venture Partners, K2 Venture Partners and lead investors from previous financings. In addition to the co-leads, new investors include MSA Capital, CBC Group, Long River Investments, LSV Capital, Superstring Capital, and Future Innovation Fund as well as a wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA). With the closing of this round, the Company has raised over $300 million to date.
Quick answer
Sironax raised $200 Million in a Series B round, dated August 2, 2022. Sironax is based in Beijing, Beijing, China.
- How much did Sironax raise?
- Sironax raised $200 Million in a Series B round on August 2, 2022.
- What does Sironax do?
- Sironax is a clinical-stage biotechnology company dedicated to the discovery and global development of novel treatments for patients with age-related degenerative diseases.
- Where is Sironax based and how big is it?
- Sironax is based in Beijing, Beijing, China.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Sironax that raised within 45 days of this round, from Fundz verified event records.
- Novome raised an undisclosed amount (Funding Round) on September 15, 2022.
- Carver raised an undisclosed amount (Seed) on September 15, 2022.
- Adaptive Biotechnologies Corporation raised an undisclosed amount (Grant) on September 12, 2022.
- Autobahn Therapeutics raised an undisclosed amount (Funding Round) on September 8, 2022.
- Photys Therapeutics raised $75M (Series A) on September 8, 2022.
- SpringWorks raised $225M (Post-IPO Equity) on September 7, 2022.
Who to call at Sironax, and when
A new round usually means Sironax is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sironax raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sironax, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sironax. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sironax raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansSironax raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.